Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes. (Q42831059)
scientific article published on December 2010
Language:
Current Data About Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes.
(P31) (Q13442814)
(P248)
(P698) 21059094
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21059094%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 16, 2020

(P50) (Q64506311)
(P1545) 3
(P248)
(P698) 21059094
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21059094%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 16, 2020

(P304) 1409-1419
(P248)
(P698) 21059094
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21059094%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 16, 2020

(P433) 12
(P248)
(P698) 21059094
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21059094%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 16, 2020

(P478) 27
(P248)
(P698) 21059094
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21059094%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 16, 2020

(P577) Wednesday, December 1, 2010
(P248)
(P698) 21059094
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21059094%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 16, 2020

(P921) (Q3025883)
(P887)

(Q909745)
(P248)
(P683) 68610

(Q19484)
(P887)

(P1433) (Q15758639)
(P248)
(P698) 21059094
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21059094%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 16, 2020

(P1476) "Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes" (language: en)
(P248)
(P698) 21059094
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21059094%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 16, 2020

(P2093) T Forst
(P1545) 1
(P248)
(P698) 21059094
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21059094%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 16, 2020

B Uhlig-Laske
(P1545) 2
(P248)
(P698) 21059094
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21059094%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 16, 2020

U Graefe-Mody
(P1545) 4
(P248)
(P698) 21059094
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21059094%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 16, 2020

C Friedrich
(P1545) 5
(P248)
(P698) 21059094
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21059094%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 16, 2020

K Herbach
(P1545) 6
(P248)
(P698) 21059094
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21059094%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 16, 2020

H-J Woerle
(P1545) 7
(P248)
(P698) 21059094
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21059094%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 16, 2020

K A Dugi
(P1545) 8
(P248)
(P698) 21059094
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21059094%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 16, 2020

(P2860) (Q36693199)
(P248)
(P854) https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03131.X
(P813) Sunday, January 21, 2018

other details
description scientific article published on December 2010

External Links
(P356) 10.1111/J.1464-5491.2010.03131.X
(P698) 21059094